GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Flora Growth Corp (FRA:7301) » Definitions » Revenue per Share

Flora Growth (FRA:7301) Revenue per Share : €5.70 (TTM As of Sep. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Flora Growth Revenue per Share?

Flora Growth's revenue per share for the three months ended in Sep. 2024 was €0.84. Flora Growth's revenue per share for the trailing twelve months (TTM) ended in Sep. 2024 was €5.70.

Warning Sign:

Flora Growth Corp revenue per share is in decline over the past 12 months.

During the past 12 months, the average Revenue Per Share Growth Rate of Flora Growth was -43.10% per year. During the past 3 years, the average Revenue Per Share Growth Rate was 491.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate.

The historical rank and industry rank for Flora Growth's Revenue per Share or its related term are showing as below:

FRA:7301' s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: 491.4   Med: 491.4   Max: 491.4
Current: 491.4

During the past 5 years, Flora Growth's highest 3-Year average Revenue Per Share Growth Rate was 491.40% per year. The lowest was 491.40% per year. And the median was 491.40% per year.

FRA:7301's 3-Year Revenue Growth Rate is ranked better than
99.45% of 910 companies
in the Drug Manufacturers industry
Industry Median: 6.4 vs FRA:7301: 491.40

Flora Growth Revenue per Share Historical Data

The historical data trend for Flora Growth's Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Flora Growth Revenue per Share Chart

Flora Growth Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Revenue per Share
- 0.04 3.62 8.23 9.48

Flora Growth Quarterly Data
Jun19 Dec19 Jun20 Dec20 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.13 1.81 1.86 1.19 0.84

Competitive Comparison of Flora Growth's Revenue per Share

For the Drug Manufacturers - Specialty & Generic subindustry, Flora Growth's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Flora Growth's PS Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Flora Growth's PS Ratio distribution charts can be found below:

* The bar in red indicates where Flora Growth's PS Ratio falls into.



Flora Growth Revenue per Share Calculation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.

Flora Growth's Revenue Per Share for the fiscal year that ended in Dec. 2023 is calculated as

Revenue Per Share (A: Dec. 2023 )=Revenue (A: Dec. 2023 )/Shares Outstanding (Diluted Average) (A: Dec. 2023 )
=69.757/7.356
=9.48

Flora Growth's Revenue Per Share for the quarter that ended in Sep. 2024 is calculated as

Revenue Per Share (Q: Sep. 2024 )=Revenue (Q: Sep. 2024 )/Shares Outstanding (Diluted Average) (Q: Sep. 2024 )
=11.231/13.353
=0.84

Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €5.70

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Flora Growth  (FRA:7301) Revenue per Share Explanation

In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.

Peter Lynch categorized companies according to their revenue growth:

Slow Grower: Inflation < 10-Year Revenue Growth Rate < 10%:
Stalwart: 10% < 10-Year Revenue Growth Rate < 20%:
Fast Grower: 10-Year Revenue Growth Rate > 20%:

His favorite companies are stalwart, those growing between 10-20% a year.

Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.


Be Aware

Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.


Flora Growth Revenue per Share Related Terms

Thank you for viewing the detailed overview of Flora Growth's Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Flora Growth Business Description

Comparable Companies
Traded in Other Exchanges
Address
3406 South West 26th Terrace, Suite C-1, Fort Lauderdale, FL, USA, 33132
Flora Growth Corp is a multi-national cannabis company that manufactures and distributes consumer packaged goods, cultivates and distributes medicinal cannabis, and distributes pharmaceutical products. Its reportable segments are; the commercial and wholesale segment (FGH and Cosechemos subsidiaries), the house of brands segment (JustCBD, Vessel, and Kasa Wholefoods Company subsidiaries), and the pharmaceuticals segment (Grupo Farmaceutico Cronomed and Breeze Laboratory subsidiaries). Geographically, the company generates revenue from United States, Germany, and the United Kingdom. It derives a majority of its revenue from the United States.

Flora Growth Headlines

No Headlines